KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $23.0 million.

  • Bionano Genomics' Total Current Liabilities fell 3026.71% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year decrease of 3026.71%. This contributed to the annual value of $37.3 million for FY2024, which is 6266.65% down from last year.
  • Latest data reveals that Bionano Genomics reported Total Current Liabilities of $23.0 million as of Q3 2025, which was down 3026.71% from $24.2 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Total Current Liabilities ranged from a high of $100.0 million in Q4 2023 and a low of $7.2 million during Q1 2021
  • Moreover, its 5-year median value for Total Current Liabilities was $32.9 million (2024), whereas its average is $32.9 million.
  • As far as peak fluctuations go, Bionano Genomics' Total Current Liabilities plummeted by 6908.31% in 2021, and later surged by 17875.38% in 2023.
  • Quarter analysis of 5 years shows Bionano Genomics' Total Current Liabilities stood at $21.8 million in 2021, then skyrocketed by 64.3% to $35.9 million in 2022, then soared by 178.75% to $100.0 million in 2023, then tumbled by 62.67% to $37.3 million in 2024, then plummeted by 38.47% to $23.0 million in 2025.
  • Its Total Current Liabilities was $23.0 million in Q3 2025, compared to $24.2 million in Q2 2025 and $26.4 million in Q1 2025.